| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535 |
| filingDate |
1996-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_629216a700af8b82060670364e41764e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b2865e1d77e7e2f28774bea948fe84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da929ca2e92e987f2ea1d4abde2f11a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b582bfb34288dd9d26aea931e096e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0276667e65e7ba215b292d3948be738f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94e22a77920d3034af93c983990cd857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08493eb4e9325fb4e79488ceb0cdbd33 |
| publicationDate |
1997-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0773217-A1 |
| titleOfInvention |
Benzothiphene derivatives for treating resistant tumors |
| abstract |
This invention provides a series of substituted benzo[b]thiophenes useful in reversing multidrug resistance in a resistant neoplasm. The present invention also provides methods for reversing the multidrug resistance in a resistant neoplasm by treating a mammal in need of said treatment with a substituted benzothiophene. This invention also provides methods for treating neoplasms in a mammal which comprises administering to a mammal in need of this treatment a substituted benzothiophene in combination with an oncolytic agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2873692-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006018544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6962928-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0875511-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056931-B2 |
| priorityDate |
1995-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |